CIK 0000921299
- Non-accelerated filer
- Smaller reporting company
KYNTRA BIO, INC.
Sign in to watch- Ticker
- KYNB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 770357827
- Phone
- +1 415-978-1200
- Business address
- 350 BAY STREET, SUITE 100 #6009, SAN FRANCISCO, CA, 94133
- Former names
- FIBROGEN INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-01-06 | Kurkijarvi Kalevi Director | Exercise or conversion | +6,000 | $18.00 | $108K | 34,400 |
| 2020-01-06 | Kurkijarvi Kalevi Director | Sale | −6,000 | $42.66 | $256K | 28,400 |
| 2020-01-06 | Kurkijarvi Kalevi Director | Exercise or conversion · Stock Option (Right to Buy) | −6,000 | 0 | ||
| 2020-01-06 | Chung Christine SVP, China Operations | Exercise or conversion | +5,625 | $25.40 | $143K | 138,269 |
| 2020-01-06 | Chung Christine SVP, China Operations | Sale | −5,625 | $42.98 | $242K | 132,644 |
| 2020-01-06 | Chung Christine SVP, China Operations | Exercise or conversion · Stock Option (Right to Buy) | −5,625 | 59,339 | ||
| 2020-01-06 | Conterno Enrique A Chief Executive Officer | Grant or award | +60,000 | 60,000 | ||
| 2020-01-06 | Conterno Enrique A Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2019-12-20 | Cotroneo Pat SVP, Finance and CFO | Exercise or conversion | +18,000 | $3.50 | $63K | 271,788 |
| 2019-12-20 | Cotroneo Pat SVP, Finance and CFO | Exercise or conversion | +21,000 | $5.95 | $125K | 292,788 |
| 2019-12-20 | Cotroneo Pat SVP, Finance and CFO | Exercise or conversion | +17,254 | $14.58 | $251K | 310,042 |
| 2019-12-20 | Cotroneo Pat SVP, Finance and CFO | Sale | −46,727 | $45.51 | $2.1M | 263,315 |
| 2019-12-20 | Cotroneo Pat SVP, Finance and CFO | Sale | −12,729 | $46.27 | $589K | 250,586 |
| 2019-12-20 | Cotroneo Pat SVP, Finance and CFO | Exercise or conversion · Stock Option (Right to Buy) | −18,000 | 0 | ||
| 2019-12-20 | Cotroneo Pat SVP, Finance and CFO | Exercise or conversion · Stock Optin (Right to Buy) | −21,000 | 0 | ||
| 2019-12-20 | Cotroneo Pat SVP, Finance and CFO | Exercise or conversion · Stock Option (Right to Buy) | −17,254 | 0 | ||
| 2019-12-17 | Chung Christine SVP, China Operations | Exercise or conversion | +5,625 | $25.40 | $143K | 138,269 |
| 2019-12-17 | Chung Christine SVP, China Operations | Sale | −5,336 | $46.95 | $251K | 132,933 |
| 2019-12-17 | Chung Christine SVP, China Operations | Sale | −289 | $47.47 | $14K | 132,644 |
| 2019-12-17 | Chung Christine SVP, China Operations | Exercise or conversion · Stock Option (Right to Buy) | −5,625 | 64,964 |
Page 24 of 33 · 651 trades